Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

To resect or not to resect? Risks and benefits of surgery in older patients with glioblastoma.

Ahmadipour Y, Rauschenbach L, Gembruch O, Darkwah Oppong M, Michel A, Pierscianek D, Stuschke M, Glas M, Sure U, Jabbarli R.

J Geriatr Oncol. 2019 Oct 28. pii: S1879-4068(19)30247-4. doi: 10.1016/j.jgo.2019.10.013. [Epub ahead of print]

PMID:
31672557
2.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
3.

Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.

Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S, Friedman AH, Adamson C.

J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.

PMID:
26452121
4.

Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.

Ahmadipour Y, Kaur M, Pierscianek D, Gembruch O, Oppong MD, Mueller O, Jabbarli R, Glas M, Sure U, El Hindy N.

J Neurol Surg A Cent Eur Neurosurg. 2019 Jul;80(4):262-268. doi: 10.1055/s-0039-1685170. Epub 2019 Apr 9.

PMID:
30965373
5.

Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era.

Kim YJ, Lee DJ, Park CK, Kim IA.

Neurosurg Rev. 2019 Dec;42(4):937-950. doi: 10.1007/s10143-018-01071-3. Epub 2019 Jan 5.

PMID:
30612289
6.

Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study.

Roh TH, Kang SG, Moon JH, Sung KS, Park HH, Kim SH, Kim EH, Hong CK, Suh CO, Chang JH.

J Neurosurg. 2019 Mar 1:1-7. doi: 10.3171/2018.12.JNS182558. [Epub ahead of print]

PMID:
30835701
7.

Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, Weingart JD, Brem H, Quiñones-Hinojosa AR.

J Neurosurg. 2009 Jan;110(1):156-62. doi: 10.3171/2008.4.17536.

PMID:
18847342
8.

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.

Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

PMID:
25434389
9.

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, Clerici E, Rossi M, Scorsetti M, Bello L.

J Neurooncol. 2017 Oct;135(1):129-139. doi: 10.1007/s11060-017-2559-9. Epub 2017 Jul 8.

PMID:
28689368
10.

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

Li YM, Suki D, Hess K, Sawaya R.

J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.

PMID:
26495941
11.

Glioblastoma surgery with and without intraoperative MRI at 3.0T.

Napolitano M, Vaz G, Lawson TM, Docquier MA, van Maanen A, Duprez T, Raftopoulos C.

Neurochirurgie. 2014 Aug;60(4):143-50. doi: 10.1016/j.neuchi.2014.03.010. Epub 2014 Jun 26.

12.

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A.

Neurosurgery. 2008 Oct;63(4):700-7; author reply 707-8. doi: 10.1227/01.NEU.0000325729.41085.73.

PMID:
18981880
13.

Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.

Chen L, Guerrero-Cazares H, Ye X, Ford E, McNutt T, Kleinberg L, Lim M, Chaichana K, Quinones-Hinojosa A, Redmond K.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):616-22. doi: 10.1016/j.ijrobp.2013.02.014. Epub 2013 Mar 26.

14.

Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis.

Almenawer SA, Badhiwala JH, Alhazzani W, Greenspoon J, Farrokhyar F, Yarascavitch B, Algird A, Kachur E, Cenic A, Sharieff W, Klurfan P, Gunnarsson T, Ajani O, Reddy K, Singh SK, Murty NK.

Neuro Oncol. 2015 Jun;17(6):868-81. doi: 10.1093/neuonc/nou349. Epub 2015 Jan 3. Review.

15.

Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?

Pala A, Schmitz AL, Knoll A, Schneider M, Hlavac M, König R, Wirtz CR, Coburger J.

Clin Neurol Neurosurg. 2018 Apr;167:6-10. doi: 10.1016/j.clineuro.2018.02.003. Epub 2018 Feb 5.

PMID:
29425743
16.

Surgical treatment of glioblastoma in the elderly: the impact of complications.

Karsy M, Yoon N, Boettcher L, Jensen R, Shah L, MacDonald J, Menacho ST.

J Neurooncol. 2018 May;138(1):123-132. doi: 10.1007/s11060-018-2777-9. Epub 2018 Feb 1.

PMID:
29392589
17.

One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?

Heiland DH, Haaker G, Watzlawick R, Delev D, Masalha W, Franco P, Machein M, Staszewski O, Oelhke O, Nicolay NH, Schnell O.

J Neurooncol. 2018 Nov;140(2):385-391. doi: 10.1007/s11060-018-2964-8. Epub 2018 Aug 3. Erratum in: J Neurooncol. 2018 Sep 10;:.

PMID:
30076585
18.

Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.

Trifiletti DM, Alonso C, Grover S, Fadul CE, Sheehan JP, Showalter TN.

World Neurosurg. 2017 Jul;103:330-340. doi: 10.1016/j.wneu.2017.04.035. Epub 2017 Apr 17.

PMID:
28427986
19.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
20.

Impact of removed tumor volume and location on patient outcome in glioblastoma.

Awad AW, Karsy M, Sanai N, Spetzler R, Zhang Y, Xu Y, Mahan MA.

J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6.

PMID:
28685405

Supplemental Content

Support Center